绿叶制药集团有限公司（港交所股票代码：02186）于2025年12月3日更新披露截至2025年11月30日的股份变动月报表，显示报告期内公司股本维持稳定，未有新增发行及股份回购活动。
公司资料显示，其法定股本为10,000,000,000股普通股，面值USD 0.02，法定股本总额USD 200,000,000，报告期内无变动。已发行股本方面，截至11月底，公司普通股已发行股份3,994,515,953股，与上月底持平，无库存股。
公告显示，绿叶制药目前存在总额为USD 180,000,000的可转债，转股价格为HKD 4.88；若全部转股，潜在发行股份数约为288,793,032股。本期并未发生新增发行或可转债转股，月末股本总数保持不变。
绿叶制药确认，11月的所有股本变动事项均遵守香港联交所《上市规则》及相关法律法规。该月报表由公司董事祝媛媛签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.